We are live on ! Find out more
FBB

Fulton Breakefield Broenniman Portfolio holdings

AUM $1.53B
1-Year Est. Return 18.11%
This Fund
S&P 500
This Quarter Est. Return
+3.4%
1 Year Est. Return
+18.11%
3 Year Est. Return
+57.23%
5 Year Est. Return
+68.56%
10 Year Est. Return
+240.26%
AUM
$490M
AUM Growth
+$33.5M
Cap. Flow
+$26.8M
Cap. Flow %
5.47%
Top 10 Hldgs %
21.92%
Holding
125
New
6
Increased
81
Reduced
25
Closed
7

Top Sells

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$3.67M
2
IBB icon
iShares Biotechnology ETF
IBB
+$2.71M
3
NKE icon
Nike
NKE
+$2.39M
4
UNP icon
Union Pacific
UNP
+$1.99M
5
MON
Monsanto Co
MON
+$1.96M

Sector Composition

Rank Sector Weight
1 Healthcare 14.14%
2 Consumer Staples 12.67%
3 Consumer Discretionary 10.92%
4 Financials 9.62%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCR
51
DELISTED
CR Bard Inc.
BCR
$4.59M 0.94%
19,529
+1,542
+9% +$335K
AMTD
52
DELISTED
TD Ameritrade Holding Corp
AMTD
$4.2M 0.86%
+147,476
New +$4.49M
ALXN
53
DELISTED
Alexion Pharmaceuticals
ALXN
$4.03M 0.82%
34,500
+484
+1% +$68.7K
ED icon
54
Consolidated Edison
ED
$40.4B
$3.95M 0.8%
49,073
-25
-0.1% -$1.88K
NVS icon
55
Novartis
NVS
$301B
$3.91M 0.8%
52,848
+1,342
+3% +$92.7K
XLNX
56
DELISTED
Xilinx Inc
XLNX
$3.89M 0.79%
84,288
+1,052
+1% +$48.1K
MCK icon
57
McKesson
MCK
$101B
$3.74M 0.76%
20,033
-1,396
-7% -$245K
NKE icon
58
Nike
NKE
$62.7B
$3.5M 0.71%
63,327
-41,915
-40% -$2.39M
STT.PRE.CL
59
DELISTED
State Street Corporation Depository Shares, each representing a 1/4,000th ownership interest in a sh
STT.PRE.CL
$3.41M 0.7%
122,135
+1,656
+1% +$44.8K
PX
60
DELISTED
Praxair Inc
PX
$3.26M 0.67%
29,012
+810
+3% +$91.9K
ROP icon
61
Roper Technologies
ROP
$38.5B
$3.2M 0.65%
18,764
-454
-2% -$79.4K
PM icon
62
Philip Morris
PM
$299B
$3.14M 0.64%
30,900
+2,169
+8% +$216K
JPM.PRG
63
DELISTED
JPMorgan Chase & Co. Depositary Shares, each representing a 1/400th interest in a share of 6.10% Non
JPM.PRG
$2.94M 0.6%
110,302
-197
-0.2% -$5.19K
ES icon
64
Eversource Energy
ES
$27.8B
$2.89M 0.59%
48,203
+2,855
+6% +$161K
SWJ.CL
65
DELISTED
STANLEY BLACK & DECKER, INC. 5.75% Junior Subordinated Debentures due 2052
SWJ.CL
$2.75M 0.56%
103,803
-500
-0.5% -$13.1K
PG icon
66
Procter & Gamble
PG
$335B
$2.65M 0.54%
31,235
-613
-2% -$50.3K
EPD icon
67
Enterprise Products Partners
EPD
$82.5B
$2.59M 0.53%
88,611
-1,948
-2% -$52.3K
PJH
68
DELISTED
MERRILL DEPOSITOR PFD PLUS 8% TST CERTS
PJH
$2.51M 0.51%
93,580
+2,409
+3% +$64.7K
TROW icon
69
T. Rowe Price
TROW
$25.6B
$2.23M 0.45%
30,544
+3,408
+13% +$254K
VWO icon
70
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$2.03M 0.41%
57,708
+6,342
+12% +$217K
IXP icon
71
iShares Global Comm Services ETF
IXP
$520M
$1.98M 0.4%
31,351
+3,218
+11% +$200K
MMM icon
72
3M
MMM
$90.8B
$1.94M 0.39%
13,218
+192
+1% +$27.1K
SCE.PRF.CL
73
DELISTED
Sce Trust I
SCE.PRF.CL
$1.92M 0.39%
72,260
+30
+0% +$776
KMB icon
74
Kimberly-Clark
KMB
$36.6B
$1.88M 0.38%
13,657
-41
-0.3% -$5.37K
WFC.PRT
75
DELISTED
WELLS FARGO & COMPANY SERIES T
WFC.PRT
$1.85M 0.38%
68,899
+1,755
+3% +$46.7K

Similar funds

Fulton Breakefield Broenniman's Q2 2016 Portfolio in Review

As of Q2 2016, Fulton Breakefield Broenniman held 125 positions worth $490M, up 7.3% from $457M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Fulton Breakefield Broenniman deployed $26.8M of net new capital in Q2 2016, opening 6 new positions and adding to 81 existing holdings. Its largest new stake was SLB Ltd: 92,206 shares worth $7.29M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Lowe's Companies, an estimated $3.67M trimmed.

  • Fulton Breakefield Broenniman's largest Q2 2016 buy was SLB Ltd: 92,206 shares worth $7.29M.
  • Fulton Breakefield Broenniman added most to Alphabet (Google) Class A in Q2 2016, an estimated $7.7M increase.
  • Fulton Breakefield Broenniman's biggest Q2 2016 reduction was Lowe's Companies, cutting an estimated $3.67M.
  • Fulton Breakefield Broenniman fully exited iShares Biotechnology ETF in Q2 2016, selling an estimated $2.71M.
  • Fulton Breakefield Broenniman's ten largest holdings make up 22% of its $490M portfolio in Q2 2016.
  • Fulton Breakefield Broenniman opened 6 new positions and closed 7 in Q2 2016.
  • Fulton Breakefield Broenniman's portfolio value rose 7.3% quarter-over-quarter to $490M.

Based on Fulton Breakefield Broenniman's 13F filing for Q2 2016, filed 2 Aug 2016.